Sage Journals: Discover world-class research

Retricted access

Research article

First published 2024-8

Does enzalutamide related PSMA upregulation affect outcomes of lutetium-177 PSMA radioligand therapy?

Turgut Bora Cengiz, Raksha Kulkarni, Matteo Novello [...]

Urologia Journal

Open access

Review article

First published 2023

Status of PSMA-targeted radioligand therapy in prostate cancer: current data and future trials

Albert Jang, Ayse T. Kendi, Oliver Sartor

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2023

Patient outcomes following a response biomarker-guided approach to treatment using 177Lu-PSMA-I&T in men with metastatic castrate-resistant prostate cancer (Re-SPECT)

Louise Emmett, Nikeith John, Sarennya Pathmanandavel [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2021-10

Therapeutic Multidose Preparation of a Ready-to-Use 177 Lu-PSMA-617 Using Carrier Added Lutetium-177 in a Hospital Radiopharmacy and Its Clinical Efficacy

Avik Chakraborty, Arpit Mitra, Megha Tawate [...]

Cancer Biotherapy and Radiopharmaceuticals

Open access

Case report

First published 2023

Safety of Lutetium-177 prostate-specific membrane antigen-617 (PSMA-617) radioligand therapy in the setting of severe renal impairment: a case report and literature review

Duncan E. K. Sutherland, Raghava Kashyap, Price Jackson [...]

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2025

Lutetium Lu 177 vipivotide tetraxetan: A literature review

Grace Morrison, Lisa M Holle

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2023

Current role of PSMA-PET imaging in the clinical management of prostate cancer

Alexander Georgakopoulos, Aristotle Bamias, Sophia Chatziioannou

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2022

Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review

Isabel Heidegger, Claudia Kesch, Alexander Kretschmer [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2024

Nomogram to predict the presence of PSMA-negative but FDG-positive lesion in castration-resistant prostate cancer: a multicenter cohort study

Jian Pan, Tingwei Zhang, Shouzhen Chen [...]

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2022-8

Update on radioligand therapy with 177 Lu-PSMA for metastatic castration-resistant prostate cancer: clinical aspects and survival effects

Valentina Fuoco, Giovanni Argiroffi, Stefania Mazzaglia [...]

Tumori Journal

Search results